An Observational Longitudinal Post-authorization Safety Study of STELARA® in the Treatment of Psoriasis and Psoriatic Arthritis: Analysis of Major Adverse Cardiovascular Events (MACE) using Swedish National Health Registers (QUANTIFY STELARA MACE)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Sweden National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  National Patient Registry (NPR) Sweden, National Patient Registry (NPR) Sweden, Cause of Death Registry (CDR) Sweden
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Drug dispensing/prescription data

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No